Decent Value Stocks. Analyze the stocks with a good fundamental valuation, while still showing decent profitability, health and growth.
MRK gets a fundamental rating of 7 out of 10. The analysis compared the fundamentals against 198 industry peers in the Pharmaceuticals industry. MRK gets an excellent profitability rating and is at the same time showing great financial health properties. MRK scores decently on growth, while it is valued quite cheap. This could make an interesting combination. MRK also has an excellent dividend rating. This makes MRK very considerable for value and dividend and quality investing!
Industry Rank | Sector Rank | ||
---|---|---|---|
ROA | 14.62% | ||
ROE | 36.96% | ||
ROIC | 19.77% |
Industry Rank | Sector Rank | ||
---|---|---|---|
OM | 34.59% | ||
PM (TTM) | 26.68% | ||
GM | 78.19% |
Industry Rank | Sector Rank | ||
---|---|---|---|
Debt/Equity | 0.74 | ||
Debt/FCF | 2.05 | ||
Altman-Z | 3.69 |
Industry Rank | Sector Rank | ||
---|---|---|---|
Current Ratio | 1.36 | ||
Quick Ratio | 1.15 |
Industry Rank | Sector Rank | ||
---|---|---|---|
PE | 10.19 | ||
Fwd PE | 8.59 |
Industry Rank | Sector Rank | ||
---|---|---|---|
P/FCF | 10.83 | ||
EV/EBITDA | 8.2 |
Industry Rank | Sector Rank | ||
---|---|---|---|
Dividend Yield | 4.15% |